No CrossRef data available.
Article contents
Management of Isolated Demyelinating Episodes by North American Neurologists
Published online by Cambridge University Press: 02 December 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Peer Reviewed Letter
- Information
- Copyright
- Copyright © The Canadian Journal of Neurological 2007
References
1.
Al-Sadat, A, Sunbulli, M, Chaturvedi, S.
Use of intravenous heparin by North American neurologists: Do the data matter?
Stroke. 2002; 33:1574–7.CrossRefGoogle ScholarPubMed
2.
Chaturvedi, S, Meinke, JL, St.Pierre, E, Bertasio, B.
Attitudes of Canadian and U.S. neurologists regarding carotid endarterectomy for asymptomatic stenosis. Can J Neurol Sci. 2000; 27:116–9.CrossRefGoogle ScholarPubMed
3.
Jacobs, LD, Beck, RW, Simon, JH, Kinkel, RP, Brownscheidle, CM, Murray, TJ, et al.
The Champs Study Group. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000; 343:898–904.CrossRefGoogle Scholar
4.
Tu, JV, Pashos, CL, Naylor, CD, Chen, E, Normand, S-L, Newhouse, JP, et al.
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med. 1997; 336:1500–5.CrossRefGoogle Scholar
5.
Laupacis, A, Evans, W.
Diagnostic imaging in Canada. Healthc Pap. 2005; 6:8–15.CrossRefGoogle ScholarPubMed
You have
Access